STEREOTACTIC Revenue and Competitors
Estimated Revenue & Valuation
- STEREOTACTIC's estimated annual revenue is currently $3.8M per year.
- STEREOTACTIC's estimated revenue per employee is $97,436
Employee Data
- STEREOTACTIC has 39 Employees.
- STEREOTACTIC grew their employee count by -2% last year.
STEREOTACTIC's People
Name | Title | Email/Phone |
---|
STEREOTACTIC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.4M | 58 | 4% | N/A | N/A |
#2 | $19.8M | 167 | 16% | N/A | N/A |
#3 | $37.4M | 285 | 5% | N/A | N/A |
#4 | $4.5M | 48 | 7% | N/A | N/A |
#5 | $2.4M | 28 | 4% | N/A | N/A |
#6 | $3.9M | 37 | -5% | N/A | N/A |
#7 | $3.8M | 39 | -2% | N/A | N/A |
#8 | $5M | 50 | 0% | N/A | N/A |
#9 | $4.8M | 45 | -6% | N/A | N/A |
#10 | $4M | 38 | -5% | N/A | N/A |
What Is STEREOTACTIC?
360 marketing. Ad agency (online and offline). Video Production. Working in Russia and across the globe www.stereotactic.ru
keywords:N/AN/A
Total Funding
39
Number of Employees
$3.8M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
STEREOTACTIC News
2022-04-13 - Stereotactic Body Radiotherapy Is a Viable Option for ...
Treatment with stereotactic body radiotherapy (SBRT) appears to be a reasonable option for patients with impaired pulmonary function and...
2022-04-13 - Dosimetry audit on stereotactic radiosurgery applications ...
This webinar presents a novel methodology for dosimetry audits on intracranial stereotactic radiosurgery applications. The succeSRS dosimetry...
2022-03-30 - Magnetic Resonance Imaging-Guided Online Adaptive Lattice ...
Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 40 | 5% | N/A |
#2 | $5.7M | 41 | -11% | N/A |
#3 | $2.4M | 44 | 5% | N/A |
#4 | $2.7M | 45 | -2% | N/A |
#5 | $3.9M | 45 | -4% | N/A |